We have located links that may give you full text access.
Cancer of the supraglottic larynx: a review of 260 patients.
Otolaryngology - Head and Neck Surgery 1985 December
The treatment of supraglottic larynx cancer is still unsettled. The current concerns are the place of conservation surgery, the use of radiation for cure with surgery for salvage, and the management of neck metastasis. In 1976, we reported our experience with treatment of 221 patients with supraglottic cancer. At that time, the issue was the oncologic safety of the conservation operations. That review affirmed that these operations were safe and effective in properly selected patients. This article is on the study of an additional 260 patients treated in a subsequent period. The principal issues addressed in this review are (1) the frequency of recurrence at the primary site in all stages of supraglottic cancer treated surgically and (2) radical radiation with surgery for salvage. This study documents the oncologic effectiveness of the treatment of primary disease with surgery alone for stages I and II supraglottic cancer. For all stages of supraglottic cancer, this study further documents that the control of neck metastasis remains an unsolved problem.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app